| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | RIBOSOMAL_S4E | 3.46e-05 | 3 | 64 | 2 | PS00528 | |
| Domain | 40S_S4_C | 3.46e-05 | 3 | 64 | 2 | IPR032277 | |
| Domain | Ribosomal_S4e_N_CS | 3.46e-05 | 3 | 64 | 2 | IPR018199 | |
| Domain | RS4NT | 3.46e-05 | 3 | 64 | 2 | PF08071 | |
| Domain | Ribosomal_S4e_central_region | 3.46e-05 | 3 | 64 | 2 | IPR013845 | |
| Domain | Ribosomal_S4e_N | 3.46e-05 | 3 | 64 | 2 | IPR013843 | |
| Domain | Ribosomal_S4e_central | 3.46e-05 | 3 | 64 | 2 | PD002667 | |
| Domain | Ribosomal_S4e | 3.46e-05 | 3 | 64 | 2 | IPR000876 | |
| Domain | Ribosomal_S4e | 3.46e-05 | 3 | 64 | 2 | PF00900 | |
| Domain | 40S_S4_C | 3.46e-05 | 3 | 64 | 2 | PF16121 | |
| Domain | S4 | 1.15e-04 | 5 | 64 | 2 | PS50889 | |
| Domain | S4 | 1.15e-04 | 5 | 64 | 2 | SM00363 | |
| Domain | S4_RNA-bd | 1.72e-04 | 6 | 64 | 2 | IPR002942 | |
| Domain | SAM_MT_RSMB_NOP | 2.40e-04 | 7 | 64 | 2 | PS51686 | |
| Domain | MeTrfase_RsmB/NOP2 | 3.19e-04 | 8 | 64 | 2 | IPR001678 | |
| Domain | - | 3.19e-04 | 8 | 64 | 2 | 2.60.40.360 | |
| Domain | Methyltr_RsmB-F | 3.19e-04 | 8 | 64 | 2 | PF01189 | |
| Domain | PapD-like | 4.10e-04 | 9 | 64 | 2 | IPR008962 | |
| Domain | KOW | 6.23e-04 | 11 | 64 | 2 | IPR005824 | |
| Domain | KOW | 6.23e-04 | 11 | 64 | 2 | PF00467 | |
| Domain | CRAL_TRIO | 2.33e-03 | 21 | 64 | 2 | PF00650 | |
| Domain | DAPIN | 2.55e-03 | 22 | 64 | 2 | PS50824 | |
| Domain | PYRIN | 2.55e-03 | 22 | 64 | 2 | PF02758 | |
| Domain | DAPIN | 2.55e-03 | 22 | 64 | 2 | IPR004020 | |
| Domain | PYRIN | 2.55e-03 | 22 | 64 | 2 | SM01289 | |
| Domain | - | 2.79e-03 | 23 | 64 | 2 | 3.40.525.10 | |
| Domain | SEC14 | 3.30e-03 | 25 | 64 | 2 | SM00516 | |
| Domain | CRAL_TRIO | 3.84e-03 | 27 | 64 | 2 | PS50191 | |
| Domain | CRAL-TRIO_dom | 4.13e-03 | 28 | 64 | 2 | IPR001251 | |
| Domain | ABC_transporter_CS | 9.11e-03 | 42 | 64 | 2 | IPR017871 | |
| Domain | UBA | 9.97e-03 | 44 | 64 | 2 | IPR015940 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 10698974 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 38474092 | ||
| Pubmed | Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. | 3.77e-06 | 2 | 68 | 2 | 16936726 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32776417 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 1783379 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 2124517 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 8187552 | ||
| Pubmed | Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. | 1.13e-05 | 3 | 68 | 2 | 22708584 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 8808278 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 9224939 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24086155 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 36640195 | ||
| Pubmed | Structure and function of ribosomal protein S4 genes on the human and mouse sex chromosomes. | 2.25e-05 | 4 | 68 | 2 | 8139551 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 12391174 | ||
| Pubmed | 3.42e-05 | 93 | 68 | 4 | 22079093 | ||
| Pubmed | Human adolescent nephronophthisis: gene locus synteny with polycystic kidney disease in pcy mice. | 3.75e-05 | 5 | 68 | 2 | 11134256 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 9562962 | ||
| Pubmed | Cooperative assembly of a protein-DNA filament for nonhomologous end joining. | 3.75e-05 | 5 | 68 | 2 | 23620595 | |
| Pubmed | Maintenance of X inactivation of the Rps4, Zfx, and Ube1 genes in a mouse in vitro system. | 3.75e-05 | 5 | 68 | 2 | 7681608 | |
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 5.30e-05 | 104 | 68 | 4 | 26167872 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 14576433 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 15613478 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 5.99e-05 | 211 | 68 | 5 | 17314511 | |
| Pubmed | An evaluation of the inactive mouse X chromosome in somatic cell hybrids. | 7.86e-05 | 7 | 68 | 2 | 8460399 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 23816522 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 7928394 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 24293640 | ||
| Pubmed | Physical mapping of 2000 kb of the mouse X chromosome in the vicinity of the Xist locus. | 1.05e-04 | 8 | 68 | 2 | 8468051 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 15640154 | ||
| Pubmed | JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. | 1.34e-04 | 9 | 68 | 2 | 20075857 | |
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 9545634 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 17998332 | ||
| Pubmed | Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. | 1.68e-04 | 10 | 68 | 2 | 11238380 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 35210568 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 18385154 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 22439931 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 29263092 | ||
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 15140983 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 2.60e-04 | 157 | 68 | 4 | 30686591 | |
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 2.90e-04 | 13 | 68 | 2 | 1740345 | |
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 2.90e-04 | 13 | 68 | 2 | 1772416 | |
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 15749123 | ||
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 11121057 | ||
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 10220430 | ||
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 28803780 | ||
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 4.90e-04 | 332 | 68 | 5 | 30595499 | |
| Pubmed | Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. | 5.65e-04 | 18 | 68 | 2 | 19084217 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 5.75e-04 | 344 | 68 | 5 | 36282215 | |
| Pubmed | Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. | 6.08e-04 | 84 | 68 | 3 | 19237606 | |
| Pubmed | 6.97e-04 | 88 | 68 | 3 | 26318153 | ||
| Pubmed | 7.00e-04 | 20 | 68 | 2 | 19668339 | ||
| Pubmed | 7.00e-04 | 20 | 68 | 2 | 16635246 | ||
| Pubmed | 7.00e-04 | 20 | 68 | 2 | 20471948 | ||
| Pubmed | 7.00e-04 | 20 | 68 | 2 | 27773593 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 7.98e-04 | 370 | 68 | 5 | 22922362 | |
| Pubmed | Proteomics analysis of the estrogen receptor alpha receptosome. | 8.18e-04 | 93 | 68 | 3 | 20348541 | |
| Pubmed | 8.48e-04 | 22 | 68 | 2 | 33903225 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.06e-03 | 394 | 68 | 5 | 27248496 | |
| Pubmed | 1.07e-03 | 102 | 68 | 3 | 26584622 | ||
| Pubmed | 1.14e-03 | 233 | 68 | 4 | 37704626 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.22e-03 | 608 | 68 | 6 | 36089195 | |
| Pubmed | Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. | 1.38e-03 | 28 | 68 | 2 | 19661089 | |
| Pubmed | 1.39e-03 | 419 | 68 | 5 | 15635413 | ||
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 1.57e-03 | 431 | 68 | 5 | 33660365 | |
| Pubmed | 1.64e-03 | 645 | 68 | 6 | 25281560 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 1.67e-03 | 647 | 68 | 6 | 26618866 | |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 1.69e-03 | 31 | 68 | 2 | 20516061 | |
| Pubmed | 1.69e-03 | 31 | 68 | 2 | 29846670 | ||
| Pubmed | 1.69e-03 | 31 | 68 | 2 | 12171929 | ||
| Pubmed | 1.69e-03 | 31 | 68 | 2 | 25817432 | ||
| Pubmed | 1.80e-03 | 32 | 68 | 2 | 23750785 | ||
| Pubmed | ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma. | 1.91e-03 | 33 | 68 | 2 | 36414381 | |
| Pubmed | 1.91e-03 | 33 | 68 | 2 | 19526283 | ||
| Pubmed | 1.91e-03 | 33 | 68 | 2 | 29950483 | ||
| Pubmed | 1.92e-03 | 1442 | 68 | 9 | 35575683 | ||
| Cytoband | 7q11.23 | 4.15e-04 | 97 | 68 | 3 | 7q11.23 | |
| GeneFamily | NOP2/Sun RNA methyltransferase family | 1.38e-04 | 7 | 47 | 2 | 664 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.09e-03 | 78 | 47 | 3 | 262 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.91e-03 | 25 | 47 | 2 | 994 | |
| GeneFamily | Autophagy related | 3.32e-03 | 33 | 47 | 2 | 1022 | |
| GeneFamily | S ribosomal proteins | 3.52e-03 | 34 | 47 | 2 | 728 | |
| ToppCell | COVID-19_Severe-MAIT|World / disease group, cell group and cell class | 2.87e-06 | 145 | 68 | 5 | 8d63f97812f63329ef9c940b291dc5a1c4d90690 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.24e-06 | 164 | 68 | 5 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 169 | 68 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.24e-06 | 170 | 68 | 5 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.41e-06 | 185 | 68 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 189 | 68 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 197 | 68 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.34e-05 | 199 | 68 | 5 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 8.19e-05 | 150 | 68 | 4 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-05 | 151 | 68 | 4 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 157 | 68 | 4 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.77e-05 | 157 | 68 | 4 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.77e-05 | 157 | 68 | 4 | 552fd5d09bbe81f58404ec38166feb30fc84def5 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.08e-04 | 161 | 68 | 4 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 162 | 68 | 4 | 2fd6e8f48b48d509a7533cec2f79089513c34a2f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 162 | 68 | 4 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 68 | 4 | ba68090d79e2243af2bdee0c27a32e65f540f8ac | |
| ToppCell | Dendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-04 | 166 | 68 | 4 | fbeb74b98b58085de323f744b18d4a8f7b22d5d4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 169 | 68 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-04 | 170 | 68 | 4 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-04 | 170 | 68 | 4 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-04 | 173 | 68 | 4 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.48e-04 | 175 | 68 | 4 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 1.48e-04 | 175 | 68 | 4 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-04 | 177 | 68 | 4 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.55e-04 | 177 | 68 | 4 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-04 | 178 | 68 | 4 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.65e-04 | 180 | 68 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-04 | 181 | 68 | 4 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 182 | 68 | 4 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.76e-04 | 183 | 68 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.76e-04 | 183 | 68 | 4 | 23e55f88a802a9299d2773f9394970e86e8bbfaa | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial-AT2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.76e-04 | 183 | 68 | 4 | 0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-04 | 186 | 68 | 4 | c7214e762b3b48197fdd0b36a50a4de2550a888f | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 187 | 68 | 4 | 88f785932e67c613db0dda84496de351359ed962 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 187 | 68 | 4 | 8896a00b30d11b90ca42726d4e122174a30b161b | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 1.95e-04 | 188 | 68 | 4 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.95e-04 | 188 | 68 | 4 | e9ed34cfea1d93eaa8e63d5b5dbb64f1520d9c4c | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-04 | 189 | 68 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.99e-04 | 189 | 68 | 4 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 1.99e-04 | 189 | 68 | 4 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.99e-04 | 189 | 68 | 4 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-04 | 190 | 68 | 4 | a51405f8466fc6d4087873137472619b2e84c1da | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-04 | 190 | 68 | 4 | 059beca1c92181b8ba4dcd6fc71ff7530d83d0de | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-04 | 191 | 68 | 4 | caed913e7ede9f8ae3af273d1ecf375de6c5e813 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-04 | 191 | 68 | 4 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.11e-04 | 192 | 68 | 4 | 5417f024fcc89eaeab33f4a2c6421d1cfabd681b | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-04 | 192 | 68 | 4 | 13e4b17d7a592604140777aca235f795df6b3f91 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-04 | 192 | 68 | 4 | f51b3fd962263920a6cae783ca7af13f5eb7aaa3 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-04 | 192 | 68 | 4 | 6244541688f85917018a057aa0b3e5972934dfbc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 194 | 68 | 4 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.20e-04 | 194 | 68 | 4 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 194 | 68 | 4 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.20e-04 | 194 | 68 | 4 | eb23b171e429165dd26a64377eae7fa2ce25f547 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.24e-04 | 195 | 68 | 4 | a2fe352682f548001ca2ee056e7a54af10134453 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 195 | 68 | 4 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-04 | 195 | 68 | 4 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | Mild-CD4+_T_activated|Mild / Disease group and Cell class | 2.29e-04 | 196 | 68 | 4 | daa1c3322d81e649161e889e1d78451d2d425d09 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-04 | 196 | 68 | 4 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.29e-04 | 196 | 68 | 4 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 197 | 68 | 4 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 197 | 68 | 4 | 8fa38fb95e285f9cc756ec4f32009be4ede09d3c | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.33e-04 | 197 | 68 | 4 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 197 | 68 | 4 | cd9172af705f9589890252ab5e8b333ed754bea4 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.38e-04 | 198 | 68 | 4 | ba3b97bb3e1533df758e845bde7d82eb1525b057 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 2.38e-04 | 198 | 68 | 4 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.38e-04 | 198 | 68 | 4 | d11097254791e415bf60a847feac81f400f11664 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.38e-04 | 198 | 68 | 4 | b2c8d5956f8449df4b69fb1b30632253440f815e | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.38e-04 | 198 | 68 | 4 | 436f3a9ef31b0991765bb97c21960f20fa71d578 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 2.38e-04 | 198 | 68 | 4 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.42e-04 | 199 | 68 | 4 | b974b495cabbcc3934936cec846c0e2442a70ac3 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 2.42e-04 | 199 | 68 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.47e-04 | 200 | 68 | 4 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 2.47e-04 | 200 | 68 | 4 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.47e-04 | 200 | 68 | 4 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-04 | 200 | 68 | 4 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | Severe-T/NK_proliferative|Severe / Disease group and Cell class | 2.47e-04 | 200 | 68 | 4 | 4723613a9f56bff422fc98722128d57b6adf3c5d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.47e-04 | 200 | 68 | 4 | 8f585920bf7ad8bb489c78e2db42435962de4416 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-04 | 200 | 68 | 4 | 3c9e0dc62d14cc00023f7f18053c1a13085d3413 | |
| Disease | Urogenital Abnormalities | 1.03e-04 | 7 | 66 | 2 | C0042063 | |
| Disease | smoking status measurement, ulcerative colitis | 3.78e-04 | 13 | 66 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | Generalized hypotonia | 5.08e-04 | 15 | 66 | 2 | C1858120 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 5.08e-04 | 15 | 66 | 2 | EFO_0004599, EFO_0007892 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HCVDVVKGLLDFKKR | 286 | Q8NAA4 | |
| FTKEIKGLKVEVTHC | 256 | Q9UL18 | |
| LVAGIKIKHLSKVFR | 526 | Q99758 | |
| SRKIKILEIFHKVGQ | 196 | Q6NXP0 | |
| KKLCQHIIKRGITVE | 456 | Q8NDN9 | |
| KFKLTAHEGCRVRKV | 846 | Q15334 | |
| RIFIQAKRVKTKHLC | 251 | Q86VD1 | |
| VHIKGNCGKEKVLFL | 326 | Q9Y5A7 | |
| GKLAKQICKVVLDHF | 11 | Q9H649 | |
| LEGVHKIICIKCKSR | 451 | Q9UBI9 | |
| EAIKALGAKHCVKEV | 211 | A0A0B4J2D5 | |
| ALEVLVKGVKIMCIH | 286 | Q8NHQ9 | |
| IKTKEIHRAIIKFLG | 306 | Q9H341 | |
| GVKTKQIRDHIVKVF | 296 | Q9H2C5 | |
| HAGKVVQKCKIQKVR | 291 | Q6P3R8 | |
| FCIKFSRHVKKLQLI | 756 | Q9C000 | |
| CIHKATRKDVAVKFV | 2701 | O60229 | |
| HIFEECIKKTLRGKT | 671 | Q96J66 | |
| IVTLCVILYKKVHKG | 16 | Q9H1C3 | |
| KHVKACVIFLKLSGL | 216 | P35410 | |
| VKEKLVCHAIIGAQK | 1016 | Q4G0P3 | |
| KKHIRTRVHFPVVKC | 771 | P0C221 | |
| AKHCVRIETKKRVLF | 396 | P13671 | |
| KRVLFAKKTKVEHRC | 406 | P13671 | |
| IHAIGIGKCKRRIVK | 186 | Q96PZ2 | |
| VLRGKIGLVHCKNVK | 601 | Q6ZN28 | |
| IGLVHCKNVKVISKE | 606 | Q6ZN28 | |
| VTKLCIHKRKIIAVA | 96 | Q9P267 | |
| EAIKALGAKHCVKEV | 211 | P0DPI2 | |
| RVKARKVHCGTVVIV | 216 | Q8N6U8 | |
| FHVVAIGRTRKKIVK | 186 | Q6SJ93 | |
| NLTVKGHAKCVEVVK | 276 | Q92769 | |
| AKKIDIIKGLFVACR | 421 | P18858 | |
| EEKEKLQKHGVCIRV | 106 | Q86SQ9 | |
| KEIVRKAVDKVCHSK | 1406 | Q99590 | |
| FSIVKIERVGKHGKV | 931 | Q16363 | |
| CNVEIKKFLGHIKRP | 51 | Q12908 | |
| LKLVCGSHSFIKVIK | 381 | P41218 | |
| KRLEKVHVVIGPKSC | 16 | Q8WUY3 | |
| RLVHKGKIDQCFKKT | 1491 | Q5K651 | |
| KIGCKNIEILHEKFI | 341 | Q8NE18 | |
| KIKRIEHAKGVCIFV | 141 | P32249 | |
| VHRITVEEAKYKLCK | 111 | P22090 | |
| VHRITVEEAKYKLCK | 111 | Q8TD47 | |
| KEKVERILKHGINCF | 276 | P78371 | |
| KKHLGIAKVVFATVR | 141 | Q9UPS6 | |
| PRKLKVCHFKKGTEI | 96 | Q9Y4P8 | |
| KHREVRVKCVKALKG | 56 | P0CL83 | |
| KLARHVFTGEKVAVK | 31 | Q9NRH2 | |
| GIFAVLKEKCGQIHK | 361 | O15269 | |
| FKVKDIIRILPCKHI | 276 | Q8NC42 | |
| VVTRKDKEACVHKIL | 606 | P02787 | |
| LVATEVCRVVKKKHR | 276 | Q8N9B8 | |
| KAIKARGEVIHCKLR | 91 | O75558 | |
| LFSICKHVLVKDIKI | 416 | Q96FJ0 | |
| SVTLEVLLVKVCHKK | 181 | Q15022 | |
| HVGFLVKTMKVLRCV | 96 | P24928 | |
| AVIINRKEHKLKKGC | 836 | Q6U841 | |
| VFRVKLTAKKLEGIH | 631 | Q92545 | |
| AVLKKLQGKDHVCRF | 66 | Q6IQ55 | |
| GVIKSLKIKYRHCLI | 321 | Q8IY51 | |
| KISKGCIKVISHIRQ | 236 | Q96MV1 | |
| KHREVRVKCVKALKG | 56 | P0CL84 | |
| VLVGLCFFVVAHVKK | 171 | Q8WVE6 | |
| KVHLKVLAGEKLYVC | 146 | Q6P3V2 | |
| DLVKKCDRHIRTVFK | 741 | O60290 | |
| KIHISKVIIGFVLKR | 46 | Q6ZRF7 | |
| KHREVRVKCVKALKG | 56 | P0CL85 | |
| VVFDHLKKLGCRIVG | 66 | Q92547 | |
| LRKLCVFKKIERHSI | 231 | P13010 | |
| GFCIDILKKLARVVK | 456 | Q14957 |